1Abu-Zidan FM, Bonham MJ, Windsor JA. Severity of acute pancreatitis: a multivariate analysis of oxidative stress markers and modified Glasgow criteria. Br J Surg, 2000,87 ( 8 ) : 1019-1023.
2Nordback I, Sand J, Saaristo R, et al. Early treatment with antibiotics reduces the need for surgery in acute necrotizing pancreatitis-a single-center randomized study. J Gastrointest Surg, 2001,5(2) :113-120.
3Imaizumi H, Kida M, Nishimaki H, et al. Efficacy of continuous regional arterial infusion of a protease inhibitor and antibiotic for severe acute panereatitis in patients admitted to an intensive care unit. Pancreas, 2004,28 (4) :369-373.
4Gloor B,Müller CA,Worni M,Martignoni ME,Uhl W,Büchler MW.Late mortality in patients with severe acute pancreatitis.Br J Surg 2001; 88:975-979.
5Alberti C,Brun-Buisson C,Burchardi H,Martin C,Goodman S,Artigas A,Sicignano A,Palazzo M,Moreno R,BoulméR,Lepage E,Le Gall R.Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study.Intensive Care Med 2002; 28:108-121.
6Hoerauf A,Hammer S,Müller-Myhsok B,Rupprecht H.Intra-abdominal Candida infection during acute necrotizing pancreatitis has a high prevalence and is associated with increased mortality.Crit Care Med 1998; 26:2010-2015.
7Edwards JE Jr,Bodey GP,Bowden RA,Büchner T,de Pauw BE,Filler SG,Ghannoum MA,Glauser M,Herbrecht R,Kauffman CA,Kohno S,Martino P,Meunier F,Mori T,Pfaller MA,Rex JH,Rogers TR,Rubin RH,Solomkin J,Viscoli C,Walsh TJ,White M.International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections.Clin Infect Dis 1997; 25:43-59.
8Petersen PJ,Jacobns NY, Weiss WJ, et al. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9 - t - butylglycylamido derivative of minocycline ( GAR - 936 ) [ J ]. Antimicrob Agents Chemother, 1999, 43 : 738 -744.
9Bradford P. Tigecycline : a first in class glycylcycline [ J ]. Clin Micro Newsl, 2004,26 : 163 - 168.
10Felmingham D. Tigecycline - the first glycylcycline to undergo clinical development: an overview of in vitro activity compared to tetracycline [ J ]. J Chemother,2005,17 ( 1 ) : 5 - 11.
4Schmidt J, Lewandrowsi K, Warshaw AL. Morphometric char- acteristics and homogeneity of a new model of acute pancreati- tis in the rat [ J ]. Int J Pancreatol, 1992,12 ( 1 ) :41-51.
5Liu X, Nakano I, Yamaguchi H, et al. Protective effect of nitric oxide on development of acute pancreatitis in rats. [ J ]. Dig Dis Sci,1995,40(10) :2162-2169.
6Molero X, Guarner F, Salas A, et al. Nitric oxide modulates pancreatic basal secretion and response to cerulein in the rat: Effects in acute pancreatitis [ J]. Gastroenterology, 1995,108 (6) :1855-1862.
7Cheng S, Yan WM, Yang B, et al. A crucial role of nitric ox- ide in acute lung injury secondary to the acute necrotizing pan- creatitis [ J]. Hum Exp Toxicol, 2010,29 ( 4 ) : 329 -337.
8Yang R, Shaufl AL, Killccn ME, et al. Ethyl pyruvate amelio- rates liver injury secondary to severe acute pancrcatitis [ J ]. J Surg Res,2009,153 ( 2 ) : 302-309.
